{"url_path":"/sec/grtx/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1563577/0001563577-26-000014-index.html","accession_number":"0001563577-26-000014","cik":"0001563577","ticker":"GRTX","issuer_name":"Galera Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1563577/0001563577-26-000014-index.html","primary_entity_key":"0001563577","primary_entity_name":"Galera Therapeutics, Inc."},"word_count":49,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n \n\nInsider trading arrangements and policies\n\nDuring the three months ended March 31, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.\n\n27"}